Zymeworks (ZYME) Gains from Investment Securities (2021 - 2023)

Historic Gains from Investment Securities for Zymeworks (ZYME) over the last 3 years, with Q4 2023 value amounting to $978000.0.

  • Zymeworks' Gains from Investment Securities fell 9045.85% to $978000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.9 million, marking a year-over-year decrease of 8100.0%. This contributed to the annual value of $3.2 million for FY2024, which is 6731.58% up from last year.
  • Latest data reveals that Zymeworks reported Gains from Investment Securities of $978000.0 as of Q4 2023, which was down 9045.85% from $423000.0 recorded in Q3 2023.
  • Over the past 5 years, Zymeworks' Gains from Investment Securities peaked at $178.7 million during Q4 2021, and registered a low of -$25.3 million during Q1 2022.
  • For the 3-year period, Zymeworks' Gains from Investment Securities averaged around $27.2 million, with its median value being $978000.0 (2023).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 9426.49% in 2022, then soared by 10197.4% in 2023.
  • Quarter analysis of 3 years shows Zymeworks' Gains from Investment Securities stood at $178.7 million in 2021, then plummeted by 94.26% to $10.2 million in 2022, then crashed by 90.46% to $978000.0 in 2023.
  • Its Gains from Investment Securities stands at $978000.0 for Q4 2023, versus $423000.0 for Q3 2023 and $499000.0 for Q1 2023.